View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Intervention News

SPONSORED CONTENT
September 18, 2024
1 min read
Save
FDA approves 160 cm endovascular navigation wire with 3D imaging guidance

FDA approves 160 cm endovascular navigation wire with 3D imaging guidance

Philips announced the FDA approved the 160 cm version of its endovascular navigation wire that uses fiber optic technology.

SPONSORED CONTENT
September 17, 2024
3 min read
Save

Premarket research not conducted for many CV devices subject to class I recall

Premarket research not conducted for many CV devices subject to class I recall

Many recently recalled cardiovascular devices did not undergo premarket testing prior to FDA approval, and postmarket studies of the devices were slow and infrequent, researchers reported.

SPONSORED CONTENT
September 13, 2024
2 min read
Save

Shared decision-making key for invasive vs. conservative MI strategy in elderly: SENIOR-RITA

Shared decision-making key for invasive vs. conservative MI strategy in elderly: SENIOR-RITA

For older adults with non-STEMI, routine coronary intervention was safe but did not lower risk for death from CV causes or nonfatal MI compared with medical therapy alone, according to new data from the SENIOR-RITA trial.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
September 10, 2024
3 min read
Save

Fasting not necessary for cardiac catheterization procedures with conscious sedation

Fasting not necessary for cardiac catheterization procedures with conscious sedation

Not fasting before cardiac catheterization procedures with conscious sedation was noninferior and likely superior to fasting for safety, and improved patient satisfaction, researchers reported at the European Society of Cardiology Congress.

SPONSORED CONTENT
September 10, 2024
3 min read
Save

TAVR superior to surgery at 1 year for women with severe aortic stenosis: RHEIA

TAVR superior to surgery at 1 year for women with severe aortic stenosis: RHEIA

Women with symptomatic severe aortic stenosis had better outcomes at 1 year after transcatheter aortic valve replacement with a balloon-expandable valve compared with women who underwent surgery, according to new data from the RHEIA trial.

SPONSORED CONTENT
September 09, 2024
2 min read
Save

Coronary implant noninferior to DES at 1 year, tied to event reduction after 6 months

Coronary implant noninferior to DES at 1 year, tied to event reduction after 6 months

The bioadaptor implant adaptable to vessel physiology was noninferior to a drug-eluting stent for target lesion failure at 1 year, and reduced event rates vs. the DES after 6 months, researchers reported.

SPONSORED CONTENT
September 03, 2024
2 min read
Save

Temporary interruption of anticoagulant use during TAVR appears safe

Temporary interruption of anticoagulant use during TAVR appears safe

Halting oral anticoagulation during transcatheter aortic valve replacement was not noninferior to anticoagulant continuation, but conferred lower bleeding risk and had no impact on thromboembolic risk, a speaker reported.

SPONSORED CONTENT
September 03, 2024
3 min read
Save

Patients with CAD undergoing TAVR may also benefit from angioplasty

Patients with CAD undergoing TAVR may also benefit from angioplasty

In patients with coronary artery disease and severe aortic stenosis undergoing transcatheter aortic valve replacement, those who also had PCI had better outcomes than those who had their CAD managed conservatively, researchers reported.

SPONSORED CONTENT
September 01, 2024
2 min read
Save

TEER noninferior to surgery in patients with heart failure, mitral regurgitation

TEER noninferior to surgery in patients with heart failure, mitral regurgitation

In patients with HF and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral valve surgery for efficacy and was linked with fewer safety endpoint events, according to data from the MATTERHORN trial.

SPONSORED CONTENT
August 31, 2024
2 min read
Save

MitraClip improves outcomes in patients with less severe mitral regurgitation, heart failure

MitraClip improves outcomes in patients with less severe mitral regurgitation, heart failure

Transcatheter mitral valve repair in addition to medical therapy led to a lower rate of CV events and hospitalizations and better health status compared with medical therapy alone for patients with HF and moderate to severe mitral regurgitation.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails